Paula A. Johnson - 23 Aug 2023 Form 5 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Director
Signature
/s/ Joleen Morgan, as attorney-in-fact for Paula A. Johnson
Issuer symbol
JNJ
Transactions as of
23 Aug 2023
Net transactions value
$0
Form type
5
Filing time
28 Jan 2026, 18:29:28 UTC
Previous filing
02 May 2023
Next filing
29 Apr 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Paula A Director ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for Paula A. Johnson 28 Jan 2026 0001341161

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Disposed to Issuer $0 -11 -11% $0.000000 89 23 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.